ciprofloxacin has been researched along with butenafine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abdulhameed, MD; Compton, JR; Friedlander, AM; Hershfield, JR; Hu, X; Jadhav, A; Leary, DH; Legler, PM; Marchand, CL; Robertson, KL; Wallqvist, A | 1 |
2 other study(ies) available for ciprofloxacin and butenafine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screening.
Topics: Amino Acid Sequence; Animals; Bacterial Proteins; Cell Line, Tumor; Cell Survival; Computational Biology; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Francisella tularensis; Humans; Indoles; Kinetics; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutation; Protein Binding; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Structure-Activity Relationship | 2013 |